Senate Democrats Release Updated Prescription Drug Pricing Bill
July 14, 2022
Last week, Senate Democrats released updated prescription drug pricing legislation, with the goal of passing it through the reconciliation process
📢 Action Needed: Tell Congress to Protect Federal Funding
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
Medicare Rights Trends Report Shows Part D Enrollees Continue to Struggle with Costs and Other Barriers to Care
June 9, 2022
This is part 3 of the helpline trends report series. Read part 1, part 2, and part 4. This third
New Campaign Urges Senate Action on Prescription Drug Pricing
May 12, 2022
Medicare Rights recently joined over 70 organizations to launch the campaign “Push For Lower Rx Prices.” The groups are calling
Drug Prices Remain High and Unpredictable as Beneficiaries Look to Lawmakers for a Fix
May 5, 2022
Medicare drug prices keep rising faster than inflation, and 8 in 10 adults say the cost of prescription drugs is
Further Evaluation of Potential Caps in Part D Shows Promise for Beneficiary Impact
April 14, 2022
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
New KFF Report Examines Beneficiary Exposure to Part B Drug Costs
March 17, 2022
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
Drug Prices Already Rising in 2022
March 10, 2022
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
Medicare Rights Supports Important Proposals for Medicare Advantage and Part D Plans
March 10, 2022
This week, Medicare Rights submitted comments on a proposed rule that would make some important changes to Medicare Advantage (MA)
Medicare Rights Joins 90 Organizations Urging Senate to Pass Drug Pricing Reforms
February 10, 2022
This week, over 90 advocacy and other organizations sent a letter to U.S. Senators, urging them to pass the drug
Letter to Senators Urging Drug Pricing Reform
February 9, 2022
Medicare Rights joined over 90 groups to urge US Senators to pass drug pricing reforms through reconciliation.
Senate Democrats Release Updated Prescription Drug Pricing Bill
July 14, 2022
Last week, Senate Democrats released updated prescription drug pricing legislation, with the goal of passing it through the reconciliation process
Medicare Rights Trends Report Shows Part D Enrollees Continue to Struggle with Costs and Other Barriers to Care
June 9, 2022
This is part 3 of the helpline trends report series. Read part 1, part 2, and part 4. This third
New Campaign Urges Senate Action on Prescription Drug Pricing
May 12, 2022
Medicare Rights recently joined over 70 organizations to launch the campaign “Push For Lower Rx Prices.” The groups are calling
Drug Prices Remain High and Unpredictable as Beneficiaries Look to Lawmakers for a Fix
May 5, 2022
Medicare drug prices keep rising faster than inflation, and 8 in 10 adults say the cost of prescription drugs is
Further Evaluation of Potential Caps in Part D Shows Promise for Beneficiary Impact
April 14, 2022
A recently released report from the Urban Institute shows that a firm limit on out-of-pocket (OOP) Part D costs, like
New KFF Report Examines Beneficiary Exposure to Part B Drug Costs
March 17, 2022
A new brief from the Kaiser Family Foundation (KFF) examines the often extreme cost liability that Part B covered drugs—typically,
Drug Prices Already Rising in 2022
March 10, 2022
A new analysis from the AARP Public Policy Institute finds drug companies have increased prices for many brand name Part
Medicare Rights Supports Important Proposals for Medicare Advantage and Part D Plans
March 10, 2022
This week, Medicare Rights submitted comments on a proposed rule that would make some important changes to Medicare Advantage (MA)
Medicare Rights Joins 90 Organizations Urging Senate to Pass Drug Pricing Reforms
February 10, 2022
This week, over 90 advocacy and other organizations sent a letter to U.S. Senators, urging them to pass the drug
Letter to Senators Urging Drug Pricing Reform
February 9, 2022
Medicare Rights joined over 90 groups to urge US Senators to pass drug pricing reforms through reconciliation.